| |
Participant and Clinical Interactions Resources (PCIR)
The Delaware Valley Unit for Participant and Clinical Interactions Resources (PCIR) will develop a single,
coordinated network to encourage and support patient-oriented clinical and translational research and will be
aligned with the governing aims of the Delaware Valley Institute for Clinical and Translational Science
(DVICTS). PCIR will provide uniform management, training and expertise for T1 (bench to patient bedside) and
T2 (bedside to general use in practice) research, and will support the translation of its research outcomes into
community practice (T3 research, see Delaware Valley Unit for Community Engagement in Research
[CER]). The guiding principle of PCIR is to provide a single platform to conduct clinical and translational
research across the four DVICTS partner institutions: Thomas Jefferson University (TJU), University of
Delaware (UD), Christiana Care Health System (CCHS), and the A.I. duPont Hospital for Children
(Nemours/AIDHC). PCIR will help both trainees and experienced investigators to develop and implement
clinical and translational studies, increase and expedite access to studies for the DVICTS community of
patients and providers, and offer unique training opportunities to develop the skills required for cutting-edge
multidisciplinary clinical and translational research. The
following outlines PCIR aims, the strategies to implement
these aims, and how success will be tracked.
-
Aim 1. PCIR will increase participation in clinical
research by both patients and providers within the
State of Delaware and the greater Delaware Valley
community, with specific efforts toward engaging
underserved populations.
-
Aim 2. PCIR will leverage its resources and ongoing
studies to train interdisciplinary teams (including
students, trainees, research personnel, and
investigators) in human clinical and translational
research.
-
Aim 3. PCIR will provide efficient and cost-effective
resources and support services within DVICTS to
investigators and trainees to conduct research
involving human participants, including both small and
large clinical and comparative effectiveness trials.
-
Aim 4. PCIR will unify clinical research across the four
DVICTS partners by improving clinical and translational
research processes and establishing cross-institutional
standard operating procedures.
The PCIR organizational structure will facilitate collaboration within DVICTS and overcome
limitations to performing clinical research. All PCIR
resources and functions will be incorporated into the DVICTS Research Commons, the web-based home for
DVICTS, which will attract both novice and experienced investigators within DVICTS and the community
networks by creating efficient, streamlined and accessible avenues for clinical and translational research. PCIR
will integrate its efforts within the community (patients and providers) through the Community Partnership
Workgroup led by CER (Aim 1). To sustain and expand these efforts within the community, PCIR will focus on
training research personnel and investigators with emphasis on cultural diversity (Aim 2) and assist trainees
and investigators as they formulate and complete T1 and T2 translational research projects in coordination with
the RETCD Clinical Translational Science Research and Education Center (CTSRE) (Aim 2). Key PCIR
resources for supporting clinical research will include the Coordinating Center for Clinical and
Translational Research (Coordinating Center), which will direct clinical and translational research within
DVICTS and into the community of Delaware and the Greater Delaware Valley (Aim 3). Additionally, the PCIR
Early Phase Research Unit (EPRU) will support the translation of basic science discoveries into human
studies (Aim 3). New investigators will work with the Clinical Project Development Workgroup (CPDW) to
transform their research concepts into actionable protocols. As a single unified entity, PCIR will establish the
Clinical and Translational Research Process Workgroup (CTRPW) to create efficient and effective clinical
and translational research processes (Aim 4). PCIR will be directed by Dr. David Whellan. Associate Directors
will be Dr. Judith Ross, Director of DVICTS Pediatric Clinical Research and Dr. Walter Kraft, Director of the
EPRU.
|